Energy News / Shareholders Foundation, Inc.

NASDAQ:IMMU Investor Alert: Investigation over Potential Wrongdoing at Immunomedics, Inc

Via: ReleaseWire

Updated 12:00 PM CST, Tue, December 19,2017

An investigation on behalf of investors in Immunomedics, Inc. (NASDAQ:IMMU) shares over potential wrongdoing at Immunomedics was announced and NASDAQ:IMMU stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 12/19/2017 -- An investigation was announced for investors in shares of Immunomedics, Inc. (NASDAQ:IMMU) was announced over potential breaches of fiduciary duties by certain officers and directors at Immunomedics.

Investors who purchased shares of Immunomedics, Inc. (NASDAQ:IMMU) and currently hold any of those NASDAQ:IMMU shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain Immunomedics directors breached their fiduciary duties and caused damage to the company and its shareholders.

Morris Plains, NJ based Immunomedics, Inc. is a clinical-stage biopharmaceutical company. Immunomedics, Inc. reported that Total Revenue declined from $3.23 million for the 12 months period that ended on June 30, 2016 to $3.09 million for the 12 months period that ended on June 30, 2017 and that its Net Loss increased over those time periods from $59.04 million to $153.21 million.

Shares of Immunomedics, Inc. (NASDAQ:IMMU) closed on December 18, 2017 at $12.69 per share.

Those who purchased shares of Immunomedics, Inc. (NASDAQ:IMMU), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqimmu-investor-alert-investigation-over-potential-wrongdoing-at-immunomedics-inc-905880.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com